In contrast to the high prevalence of FGFR3 mutations in urine from patients with confirmed bladder tumor (67%), only one of the patients with benign histopathology had a FGFR3 mutation detectable in urine. The gene discussed is FGFR3; the disease is urinary bladder neoplasm.